Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gamma-hydroxybutyrate in experimental myoclonus

M K Menon

    Neurology
    |April 1, 1982
    PubMed
    Summary

    Sodium gamma-hydroxybutyrate effectively blocked muscimol-induced myoclonic jerks in mice. This finding suggests potential therapeutic value for gamma-hydroxybutyrate in treating Lance-Adams syndrome and other myoclonus conditions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Morphogenetic role of kinetin and abscisic acid in the moss Physcomitrium.

    Planta·2014
    Same author

    Ultrastructural and cytochemical aspects of induced apogamy following abscisic acid pre-treatment of secondary moss protonema.

    Planta·2013
    Same author

    Comment 1: dual parental consent.

    Annals of the Royal College of Surgeons of England·2009
    Same author

    Stem cell plasticity: an overview.

    Blood cells, molecules & diseases·2004
    Same author

    Tissue injury in marrow transdifferentiation.

    Blood cells, molecules & diseases·2004
    Same author

    Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2001

    Area of Science:

    • Neuropharmacology
    • Experimental Neurology

    Background:

    • Muscimol, a GABA receptor agonist, induces myoclonic jerks in rodents.
    • Postanoxic action myoclonus (Lance-Adams syndrome) is a severe neurological disorder characterized by involuntary muscle jerks.

    Purpose of the Study:

    • To investigate the potential of sodium gamma-hydroxybutyrate (GHB) as an anticonvulsant agent.
    • To evaluate the efficacy of GHB in blocking drug-induced myoclonus.

    Main Methods:

    • Administration of muscimol intraperitoneally to Swiss mice to induce myoclonic jerks.
    • Pretreatment with varying doses of sodium gamma-hydroxybutyrate (50-200 mg/kg) to assess its blocking effect.
    • Observation and quantification of myoclonic jerk frequency and intensity.

    Main Results:

    • Muscimol induced frequent, repetitive myoclonic jerks in the hindquarters of mice.
    • Sodium gamma-hydroxybutyrate demonstrated a dose-dependent blockade of muscimol-induced jerks.
    • GHB was also effective in nullifying already established muscimol responses.

    Conclusions:

    • Sodium gamma-hydroxybutyrate exhibits significant anticonvulsant properties against muscimol-induced myoclonus in mice.
    • The findings support the potential therapeutic application of GHB in managing Lance-Adams syndrome and other forms of myoclonus.
    • GHB's mechanism may involve modulation of GABAergic pathways relevant to myoclonus pathogenesis.

    Related Experiment Videos